Keyword: Sanofi

Markets & Companies

2017 Through the Rear-view Mirror

08.01.2018 - On the pharmaceutical side, super-dimensioned M&A activity was somewhat more modest. Many of the deals were between players in the biochemicals segment or conventional drugmakers...

Markets & Companies

2017 Through the Rear-view Mirror

08.01.2018 - The chemical production sector saw more activity than pharmaceuticals in 2017. Beyond the mega-mergers, one of the most significant deals of 2017 was BASF’s announcement in early...

Markets & Companies

2017 Through the Rear-view Mirror

08.01.2018 - Mergers and acquisitions, new petrochemical projects, the dismantling of US environmental regulations, and a tussle over the hazards of pesticides in Europe, along with a...

News

Teva Realigns, may Slash 25% of Workforce

04.12.2017 - Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...

Markets & Companies

The German Capital Region

24.11.2017 -

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500...

News

Sanofi, Principia to Develop MS Candidate

16.11.2017 - French drugmaker Sanofi has signed an agreement to develop Principia Biopharma’s experimental oral treatment that is seen to show promise in treating multiple sclerosis (MS) and...

News

Sanofi Charges Mylan With Lantus Breach

07.11.2017 - Sanofi is pursuing another US competitor for alleged breach of the patent for its top-selling diabetes drug insulin glargine (branded as Lantus and Lantus SoloStar), which together...

News

Pfizer to Launch Consumer Health Sale Soon?

26.10.2017 - US drugs giant Pfizer is poised to kick off the long awaited sale of its $3.4 billion consumer health unit next month, news agencies speculate. According a calculation by Reuters...